Trazograf 0.66gm/0.1gm Infusion
Marketer
J B Chemicals and Pharmaceuticals Ltd
Salt Composition
Meglumine Diatrizoate (0.66gm) + Sodium Diatrizoate (0.1gm)
Overview Trazograf 0.66gm/0.1gm Infusion
Iopamidol and meglumine iopamidol injection (0.66gm/0.1gm) is a dual-contrast imaging agent. This medication facilitates visualization of internal organs and their activity for precise diagnosis, contributing to proactive disease management. Administration must be performed by qualified medical personnel under strict physician oversight. While temporary discomfort and localized irritation are possible, these side effects typically resolve spontaneously. Prior to use, complete disclosure of any existing medical conditions, including cardiovascular, hepatic, or renal impairment, is crucial. Pregnant or lactating individuals require special consideration. Seek immediate medical attention for any signs of an allergic response, such as respiratory distress, edema, or cutaneous eruptions.
Primary Ingredients of Trazograf 0.66gm/0.1gm Infusion
No text provided. Please provide the text you wish me to rewrite.
Uses of Trazograf 0.66gm/0.1gm Infusion
Imaging contrast medium
Major Benefits of Trazograf 0.66gm/0.1gm Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Trazograf 0.66gm/0.1gm Infusion:
- Nausea
- Vomiting
- Vasodilation
- Paresthesia (tingling or pricking sensation)
- Dizziness
- Inflammation of the nose
- Cough
- Urticaria
- Injection site pain
- Painful erythematous swelling
- Taste change
- Osmotic nephrosis
How to use Trazograf 0.66gm/0.1gm Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Trazograf 0.66gm/0.1gm Infusion works:
Trazograf infusion, containing 0.66gm meglumine diatrizoate and 0.1gm sodium diatrizoate, utilizes a dual radiopaque contrast agent for intravenous administration. This facilitates visualization of internal organs and their activity during diagnostic imaging, aiding in the early detection and prevention of potential health issues.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Trazograf 0.66gm/0.1gm Infusion has an undetermined safety profile. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Trazograf 0.66gm/0.1gm Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to any prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Trazograf 0.66gm/0.1gm Infusion during lactation appears to be unlikely to cause harm. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Trazograf 0.66gm/0.1gm Infusion on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Trazograf 0.66gm/0.1gm Infusion to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Trazograf 0.66gm/0.1gm Infusion use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Trazograf 0.66gm/0.1gm Infusion :
NA
Facts to Know About Trazograf 0.66gm/0.1gm Infusion
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | ALTERNATIVES |
3,018 People bought this recently